Medicare AdvantageCoverageMedium impact
MA11.004m, Minimally Invasive Treatments for Urinary Outlet Obstruction due to Benign Prostatic Hyperplasia (BPH)
Independence Blue Cross·Urology·Medical Policy
Effective date
Jan 1, 2025
We identified it
Jun 19, 2026
Summary
MA11.004m policy for minimally invasive treatments for urinary outlet obstruction due to benign prostatic hyperplasia (BPH) has been updated for Medicare Advantage plans. This fresh policy update affects coverage and billing requirements for BPH treatments, though specific billing codes and detailed changes are not provided in the summary information.
Action Required
Immediately: Review the full MA11.004m policy document at the provided URL to understand specific coverage changes for minimally invasive BPH treatments under Medicare Advantage plans. Update billing procedures and prior authorization requirements as specified in the complete policy text. Ensure all BPH-related claims comply with new coverage criteria effective January 1, 2025.